1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Receptor ROR-Gamma Revenue
1.4 Market Analysis by Type
1.4.1 Global Nuclear Receptor ROR-Gamma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 VPR-66
1.4.3 INV-17
1.4.4 GSK-2981278
1.4.5 BBI-6000
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nuclear Receptor ROR-Gamma Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nuclear Receptor ROR-Gamma Market
1.8.1 Global Nuclear Receptor ROR-Gamma Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Nuclear Receptor ROR-Gamma Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Receptor ROR-Gamma Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Nuclear Receptor ROR-Gamma Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Receptor ROR-Gamma Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Nuclear Receptor ROR-Gamma Sales Volume Market Share by Region (2015-2020)
3.2 Global Nuclear Receptor ROR-Gamma Sales Revenue Market Share by Region (2015-2020)
3.3 North America Nuclear Receptor ROR-Gamma Sales Volume
3.3.1 North America Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.3.2 North America Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Nuclear Receptor ROR-Gamma Sales Volume
3.4.1 East Asia Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.5.1 Europe Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.6.1 South Asia Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.7.1 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.8.1 Middle East Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.9.1 Africa Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.10.1 Oceania Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.11.1 South America Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.11.2 South America Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Nuclear Receptor ROR-Gamma Sales Volume (2015-2020)
3.12.1 Rest of the World Nuclear Receptor ROR-Gamma Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Nuclear Receptor ROR-Gamma Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Nuclear Receptor ROR-Gamma Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Nuclear Receptor ROR-Gamma Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Nuclear Receptor ROR-Gamma Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Nuclear Receptor ROR-Gamma Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Nuclear Receptor ROR-Gamma Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Nuclear Receptor ROR-Gamma Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Nuclear Receptor ROR-Gamma Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Nuclear Receptor ROR-Gamma Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Nuclear Receptor ROR-Gamma Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Nuclear Receptor ROR-Gamma Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Nuclear Receptor ROR-Gamma Sales Volume Market Share by Type (2015-2020)
14.2 Global Nuclear Receptor ROR-Gamma Sales Revenue Market Share by Type (2015-2020)
14.3 Global Nuclear Receptor ROR-Gamma Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Nuclear Receptor ROR-Gamma Consumption Volume by Application (2015-2020)
15.2 Global Nuclear Receptor ROR-Gamma Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Nuclear Receptor ROR-Gamma Business
16.1 4SC AG
16.1.1 4SC AG Company Profile
16.1.2 4SC AG Nuclear Receptor ROR-Gamma Product Specification
16.1.3 4SC AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Celgene Corporation
16.2.1 Celgene Corporation Company Profile
16.2.2 Celgene Corporation Nuclear Receptor ROR-Gamma Product Specification
16.2.3 Celgene Corporation Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Aurigene Discovery Technologies Limited
16.3.1 Aurigene Discovery Technologies Limited Company Profile
16.3.2 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Product Specification
16.3.3 Aurigene Discovery Technologies Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Advinus Therapeutics Ltd.
16.4.1 Advinus Therapeutics Ltd. Company Profile
16.4.2 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Product Specification
16.4.3 Advinus Therapeutics Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Bristol-Myers Squibb Company
16.5.1 Bristol-Myers Squibb Company Company Profile
16.5.2 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Product Specification
16.5.3 Bristol-Myers Squibb Company Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Arrien Pharmaceuticals, LLC
16.6.1 Arrien Pharmaceuticals, LLC Company Profile
16.6.2 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Product Specification
16.6.3 Arrien Pharmaceuticals, LLC Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Genfit SA
16.7.1 Genfit SA Company Profile
16.7.2 Genfit SA Nuclear Receptor ROR-Gamma Product Specification
16.7.3 Genfit SA Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Brickell Biotech, Inc.
16.8.1 Brickell Biotech, Inc. Company Profile
16.8.2 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.8.3 Brickell Biotech, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Biogen, Inc.
16.9.1 Biogen, Inc. Company Profile
16.9.2 Biogen, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.9.3 Biogen, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Genentech, Inc.
16.10.1 Genentech, Inc. Company Profile
16.10.2 Genentech, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.10.3 Genentech, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Nuevolution AB
16.11.1 Nuevolution AB Company Profile
16.11.2 Nuevolution AB Nuclear Receptor ROR-Gamma Product Specification
16.11.3 Nuevolution AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Teijin Pharma Limited
16.12.1 Teijin Pharma Limited Company Profile
16.12.2 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Product Specification
16.12.3 Teijin Pharma Limited Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 GlaxoSmithKline Plc
16.13.1 GlaxoSmithKline Plc Company Profile
16.13.2 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Product Specification
16.13.3 GlaxoSmithKline Plc Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Vitae Pharmaceuticals, Inc.
16.14.1 Vitae Pharmaceuticals, Inc. Company Profile
16.14.2 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.14.3 Vitae Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Phenex Pharmaceuticals AG
16.15.1 Phenex Pharmaceuticals AG Company Profile
16.15.2 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Product Specification
16.15.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Lead Pharma Holding B.V.
16.16.1 Lead Pharma Holding B.V. Company Profile
16.16.2 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Product Specification
16.16.3 Lead Pharma Holding B.V. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Hanmi Pharmaceuticals, Co. Ltd.
16.17.1 Hanmi Pharmaceuticals, Co. Ltd. Company Profile
16.17.2 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Product Specification
16.17.3 Hanmi Pharmaceuticals, Co. Ltd. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Visionary Pharmaceuticals, Inc.
16.18.1 Visionary Pharmaceuticals, Inc. Company Profile
16.18.2 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.18.3 Visionary Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Reata Pharmaceuticals, Inc.
16.19.1 Reata Pharmaceuticals, Inc. Company Profile
16.19.2 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Product Specification
16.19.3 Reata Pharmaceuticals, Inc. Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Karo Bio AB
16.20.1 Karo Bio AB Company Profile
16.20.2 Karo Bio AB Nuclear Receptor ROR-Gamma Product Specification
16.20.3 Karo Bio AB Nuclear Receptor ROR-Gamma Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Nuclear Receptor ROR-Gamma Manufacturing Cost Analysis
17.1 Nuclear Receptor ROR-Gamma Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nuclear Receptor ROR-Gamma
17.4 Nuclear Receptor ROR-Gamma Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Nuclear Receptor ROR-Gamma Distributors List
18.3 Nuclear Receptor ROR-Gamma Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Nuclear Receptor ROR-Gamma (2021-2026)
20.2 Global Forecasted Revenue of Nuclear Receptor ROR-Gamma (2021-2026)
20.3 Global Forecasted Price of Nuclear Receptor ROR-Gamma (2015-2026)
20.4 Global Forecasted Production of Nuclear Receptor ROR-Gamma by Region (2021-2026)
20.4.1 North America Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.3 Europe Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.7 Africa Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.9 South America Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Nuclear Receptor ROR-Gamma Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Nuclear Receptor ROR-Gamma by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.2 East Asia Market Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.3 Europe Market Forecasted Consumption of Nuclear Receptor ROR-Gamma by Countriy
21.4 South Asia Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.5 Southeast Asia Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.6 Middle East Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.7 Africa Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.8 Oceania Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.9 South America Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
21.10 Rest of the world Forecasted Consumption of Nuclear Receptor ROR-Gamma by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer